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Summary Positron emission tomography (PET) with [18F]-fluoro-2-deoXy-D-glucose (FDG) was prospectively investigated as a means of
detecting metastatic disease in patients with oesophageal tumours and compared with computerized tomography (CT), with the surgical
findings as a gold standard. Twenty-six patients with a malignant tumour of the oesophagus or gastroesophageal junction underwent CT and
PET of the chest and the abdomen. Seven patients underwent laparoscopy to establish resectability. Fifteen patients underwent laparotomy
without prior laparoscopy. Four patients did not undergo surgery. The primary tumour was visualized in 81% of patients with CT and in 96%
with PET. Neither CT nor PET were suited to assess the extent of wall invasion. Surgically assessed nodal status corresponded in 62% with
CT and in 90% with PET. Distant metastases were found in five patients with CT and in eight with PET. The diagnostic accuracy of CT in
determining resectability was 65% and for PET 88%. For CT and PET together this was 92%. The present study indicates that FDG-PET can
be of importance for staging patients with oesophageal tumours. PET has a higher sensitivity for nodal and distant metastases and a higher
accuracy for determining respectability than CT. PET and CT together would have decreased ill-advised surgery by 90%.
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The increase in incidence of adenocarcinoma of the oesophagus
and the gastroesophagealjunction exceeds that ofall other types of
cancer (DeMeester, 1993). Surgery is still the only possibility for
cure and long-term palliation for tumours in stages I and II.
However, adenocarcinoma of the gastroesophageal junction and
the oesophagus usually (50-80%) presents in an advanced stage of
the disease (stage IIIB/IV). Patients with such locally advanced
tumours have a poor prognosis, with a median survival of about 6
months. After surgical resection, the 5-year survival rate is only
12% in stage III disease and all patients with stage IV disease die
within 1 year (Moreaux and Horiot, 1980; de Calan et al, 1988;
Masurin et al, 1992; Rahamim and Cham, 1993). Because the
prognosis decreases rapidly with more advanced stages and pallia-
tive oesophagectomy is not associated with increased survival,
resection should not be offered to patients with stage IIIB/IV
disease (Eeftinck Schattenkerk et al, 1987; Masurin et al, 1992).
These patients can be treated with preoperative chemotherapy and
should only be operated on in case of response to treatment
(Plukker et al, 1991, 1995; Bamias et al, 1996; Stahl et al, 1996).
For initial staging computerized tomography (CT) is used, but
this method has limited sensitivity for this indication (Lehr et al,
1988; Sussman et al, 1988; Watt et al, 1989; Bonavina et al, 1997;
Saunders et al, 1997). Endoscopic ultrasonography (EUS) is more
accurate for establishing local tumour invasion and regional lymph
node metastasis, but passing the probe through a stenotic tumour
may be impossible in aconsiderable number(20-50%) ofcases (Tio
et al, 1989; Grimm et al, 1993; Vilgrain et al, 1990; Ziegler et al,
1991; Dittler and Siewert, 1993). Furthermore, as EUS is not an
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appropriate method for assessing nodal involvement at the coeliac
axis, metastases in the right liver lobe and peritoneal dissemination
- although some improvement can be obtained with fine-needle
aspiration cytology during EUS (Tio et al, 1989; Lightdale, 1992;
Dittler and Siewer, 1993) - explorative laparoscopy or laparotomy
to assess metastatic disease and to estimate the possibility of
resecting the tumour with curative intent usually remains necessary.
Laparoscopy fails to detect locally irresectable or metastatic disease
in 20% of patients, whereas in approximately 30% there are no
therapeutic options at explorative laparotomy (Molloy et al, 1995)
Positron emission tomography (PET) offers the possibility ofinves-
tigating the glucose metabolism of tumours in vivo, with the use
of the radiopharmaceutical [18F]fluoro-2-deoxy-D-glucose (FDG).
Tumours with a high glucose metabolism such as oesophageal
cancer, also have a high FDG consumption (Yasuda et al, 1995).
Animal experiments with human gastric cancer xenografts also
showed that FDG uptake is correlated with the differentiation ofthe
tumour (Yoshioka et al, 1994). PET has already established a role in
the staging of other tumours such as lung cancer and colon cancer
(Valk et al, 1995; Vitola et al, 1996; Delbeke et al, 1997; Guhlmann
et al, 1997; Steinert et al, 1997). The current study was undertaken
to investigate FDG-PET prospectively as a means of detecting
metastatic disease in patients with oesophageal tumours and of
comparing the reliability ofdiagnostic assessment ofPET with CT,
with the surgical and histological findings as a gold standard.
PATIENTS AND METHODS
Patients
Twenty-six consecutive patients, [22 men and four women
(patients 4, 9, 12 and 24 in Table 1), with a mean age of 60 years
Part ofthis study was presented at the Society of Surgical Oncology, 20-23 March
1997, Chicago, USA.
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Table 1 Patient characteristics (histology and tumour location, size at gastroesophagoscopy) and staging results (of CT, PET, EUS, laparoscopy and
laparotomy) with an estimate of resectability from each investigation
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Glucose infusion before PET
Multifocal tumour
Mural tumour
T3N2MO R Nodal stage could not be assessed with
CT because of absence of fat
T4NOMO R PET suggested the tumour to be











EUS probe could not pass the tumour;
the liver lesion on CT appeared to be a
haemangioma at biopsy; the tumour was
resected but the surgical margins were
not free
5 T4N2M1 NR T+N2M1 NR NP T3NOMO R T4N2Mx NR Distant metastases were not investigated
at laparotomy
5 T+NOMO R T+N2MO NR NP T+NOMO R TxN2MO NR Primary tumour was not investigated at
laparotomy
10 T+NxMx T+N2Mliver & T3N1MO R NP TxN2Mx NR N2 and liver metastases dubious on CT;
lung NR distant metastases not investigated at
laparotomy
8 T4N3MO NR T4N1MO NR T4N1MO NR NP NP Locally advanced disease
3 TONOMO R T+NOMliver NR NP TxNxMliver NR NP Primary tumour and nodal status were
not investigated at laparoscopy
4 T+N1 Mscl NR T+N1Mscl NR NP NP NP Positive supraclavicular FNA
5 T+NOMlung NR T+N2Mlung NR NP NP NP Locally advanced tumour above tracheal
bifurcation
8 T4N2MO NR T4N2Mscl NR T4N1 MO R NP NP Positive supraclavicular FNA
AC, adenocarcinoma; SCC, squamous cell carcinoma; GJ, gastroesophageal junction; T+, primary tumour seen but not further classified; Nx, N-stage not
conclusive; Mx, M-stage not conclusive; NP, not performed; SCL, supraclavicular; R, resectable; NR, non-resectable; *, size at histological examination; FNA,
fine-needle aspiration cytology.
(range 41-76)] were included. All gave informed consent. The
study protocol was approved by the Medical Ethics Committee of
Groningen University Hospital. All patients had a biopsy-proven
malignancy of the distal oesophagus (n = 13) or gastroesophageal
junction (n = 13). In one patient, PET demonstrated a tumour in
the proximal to the middle third of the oesophagus instead of the
distal oesophagus. Adenocarcinoma accounted for 21 tumours,
squamous cell carcinoma for four and one patient had a malignant
stroma cell tumour. Patient characteristics are presented in Table 1.
All patients underwent CT and PET of the chest and the abdomen
before surgery. The need for EUS, laparoscopy and laparotomy
was determined for each patient individually. Seven patients
underwent laparoscopy to establish resectability. Fifteen patients
underwent laparotomy without prior laparoscopy. In seven
patients, it was made obvious by CT and EUS and confirmed by
PET findings that surgery was no longer a therapeutic option,
because of N2 or distant metastases. Three of these patients were
included in a neoadjuvant chemotherapy protocol that required
surgical staging; in the other four patients surgery was given up.
CT and EUS
In our institute, CT is the standard radiographic method of
assessing tumour stage and hence resectability with curative intent.
Spiral CT scanning was carried out on fourth-generation units
(SR7000, Philips Medical Systems, Best, The Netherlands; or
Somatron Plus 4 spiral CT, Siemens Medical Systems, Erlangen,
Germany) at 10-mm overlapping parts after both oral and intra-
venous contrast. All CT scans were interpreted independently of
the PET findings, but with knowledge of the EUS findings ifavail-
able. Perioesophageal invasion was considered present in case of
direct invasion into the surrounding tissues or absence of fat
cleavage planes between the tumour and adjacent organs. Lymph
nodes were considered positive when the short axis was greater
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than I cm in diameter. Lesions in the liver not characteristic of a
cyst or haemangioma were considered suspicious for metastases.
EUS was carried out with a GUM20 (Olympus, Tokyo, Japan).
The depth of infiltration was determined and lymph nodes larger
than 5 mm that were homogeneous, round, distinctly delineated
and without a hyperechogenic texture were considered suspicious
for metastases.
PET studies
FDG was routinely produced by a robotic system following the
procedure described by Hamacher et al (1986), with a radiochem-
ical purity of more than 98%. A 951/31 ECAT positron camera
(Siemens/CTI, Knoxville, USA) was used for data acquisition.
This device has a 56-cm-diameter patient aperture and acquires 31
planes simultaneously over a 10.8-cm axial field of view. Twenty-
five patients were fasted at least 8 h in a hospital setting before the
PET examination. None of the patients was diabetic. One patient
received a glucose infusion until 1 h before the PET investigation
as a result of confusion over the term 'fasted'. FDG (10 mCi) was
administered intravenously. After 30 min the patients were posi-
tioned supine in the camera and activity was counted 3 min per
body position of 10.8 cm from neck to pelvis. Because of time
constraints no transmission scan for attenuation correction was
obtained. Using standard ECAT software, images were recon-
structed and displayed in coronal, transaxial and sagittal slices.
All PET images were interpreted without knowledge of the CT
findings or EUS data, and were evaluated with respect to local
tumour extension, nodal involvement, distant metastases and
resectability with curative intent. Uptake higher than background
was considered to be increased. Because ofthe absence ofattenua-
tion correction no quantitative measurements could be obtained.
Difference in sensitivity was tested using the McNemar test and a
P-value of < 0.05 was considered to be significant.
Surgery
Objectivity of surgical findings was assured by histological exam-
ination ofthe resected specimen or, ifno resection was performed,
tissue samples. Findings precluding cure by primary surgery were
fixation of the aorta, metastatic lymph nodes at the coeliac axis or
the upper border of the pancreas and distant metastases. During
surgery with curative intent all macroscopically malignant disease
was removed by en bloc resection of adjacent structures and
extended lymph node dissection.
RESULTS
The results of all staging investigations and an estimate of
resectability are listed in Table 1. Based on CT, EUS and PET find-
ings explorative laparoscopy or laparotomy was not performed in
four patients. In two of these patients (nos 24 and 26) supraclavic-
ular metastases were established (in both with PET and in one with
CT) (Figure 1). They were confirmed with fine-needle aspiration
cytology. In a third patient (no. 25) multiple pulmonary metastases
were seen, and in the fourth patient (no. 22) extensive local tumour
invasion was visualized with CT and EUS, which was also
confirmed by PET (Figure 2).
Of the other 22 patients, seven underwent laparoscopy to estab-
lish resectability. In two of these patients laparoscopy revealed an
unresectable tumour: in one (patient 17) because oflocally extensive
Figure 1 FDG-PET whole-body image of the thorax and abdomen of a 50-
year-old male patient (patient 24) with a carcinoma of the oesophagus. PET
demonstrated high uptake of FDG in left and right supraclavicular lymph
nodes (arrows). Fine-needle aspiration cytology proved these lymph nodes to
be malignant and surgery was not performed. T, primary tumour; K, kidney; B,
brain
disease, and in the other (patient 23) because of histologically
proven liver metastases (Figure 3). In the remaining five patients
resection appeared feasible, and laparotomy was performed in an
attempt to resect the tumour. However, the tumourcould be resected
in only one ofthese five patients (no. 1). Laparotomy was performed
in a total of 20 patients. Of these, ten (patients 1-7 and 9-11) had
resectable disease and the specimen margins were microscopically
free oftumour. Histological examination ofthe resected specimen in
patient 9 revealed positive lymph nodes at the N2 level that were not
suspected at surgery.
Primary tumour stage
The primary tumour was visualized in 21 patients with CT (81%).
Those missed had a length of 0.5, 0.8, 2.5, 3 and 6 cm at gastro-
esophagoscopy. In 25 patients the primary tumour was visualized
with PET (96%). The one that was missed measured 0.5 cm. This
tumour concerned the patient who had had the glucose infusion.
The difference in sensitivity between CT and PET for detecting the
primary tumour was not significant (P = 0.06; McNemar-test).
Neither CT nor PET were suited to assess the extent of wall
invasion, although in some patients in whom surgery revealed a T4
tumour (n = 10), this was suggested with CT in two patients and
with PET in four patients (Figure 2). In the patient with a malignant
stroma cell tumour, CT clearly visualized its limitation to the
oesophageal wall. EUS was performed in seven patients. In one
patient, the probe could not pass the stenotic tumour. In one patient
the extent ofwall invasion was underestimated and in three patients
there was no histological examination to confirm the EUS result.
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Figure 2 FDG-PET whole-body images of the thorax and abdomen of two
male patients (A; patient 17; B patient 18), both with a carcinoma of the
gastroesophageal junction in whom locally advanced disease is
demonstrated. The large area of high FDG uptake reaches towards the left
kidney and is strongly suggestive of a T4 tumour. CT could not visualize this
feature in patient 13, but it was confirmed at laparotomy. T, primary tumour;
K, kidney
Nodal stage
Nodal status was assessed surgically in 22 patients. This corre-
sponded in 13 patients (accuracy 62%) with the CT findings. If a
patient was staged N1 at CT, but N2 at surgery, this was consid-
ered a false-negative result. In five patients, para-aortic and
coeliac trunk metastases were missed, in one patient nodal dissem-
ination to the hepatoduodenal ligament was not made visible, and
in two patients CT was inconclusive concerning the nodal stage.
There were no false-positive results with CT, but in only 5 out of
13 patients with lymph node metastases, these were detected with
CT (sensitivity 38%, specificity 100%). With PET, 19 of 21
Figure 3 Coronal slice of a FDG-PET whole-body image of the abdomen of
a 65-year-old male patient (patient 23) with a carcinoma of the
gastroesophageal junction (not shown in this slice). PET shows high focal
uptake of FDG in the liver (arrow). This lesion was not visualized with CT but
confirmed during laparoscopy.
patients were correctly staged (accuracy 90%) (Figure 4). In one
patient metastasis at the lesser omentum was missed. In another
patient a multifocal tumour was interpreted as one tumour with
locoregional metastases. The sensitivity and specificity ofPET for
lymph node metastases were 92% (12/13) and 88% (7/8) respec-
tively. The difference in sensitivity between CT and PET was
significant (P = 0.02; McNemar-test). With EUS, two out of five
patients were correctly staged. In one patient coeliac trunk metas-
tases were missed, in one patient EUS showed false-positive local
lymph node metastases and in the third patient the tumour could
not be passed with the probe. In two patients there was no histo-
logical examination to confirm the EUS result.
Distant metastases
Distant metastases were found in five patients with CT and in
eight patients with PET. CT was false positive in a liver haeman-
gioma. In one patient (no. 9) PET showed supraclavicular uptake,
which was categorized under distant metastases, but fine-needle
aspiration cytology could not confirm the presence of metastasis
(Figure 5). In retrospect, this feature most probably represented
asymmetric uptake in muscles. In another patient (no. 10) high
rectal FDG-uptake was seen. Because this would be an unusual
metastatic site, colonoscopy was advised, which revealed colitis.
In two patients the distant metastases in the liver and lungs as
established with PET and/or CT were not histologically investi-
gated. No distant metastases were found with EUS.
Resectability
Resectability is determined by taking into account the combined
findings concerning primary tumour, lymph node metastases and
distant metastases. PET suggested resectability in I I patients and
non-resectability in the remaining 15. This reading was not correct
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Figure 4 FDG-PET whole-body image of the abdomen of a 56-year-old
male patient (patient 16) with a carcinoma of the gastroesophageal junction
with high focal para-aortic uptake of FDG suggestive of retroperitoneal lymph
node metastases (arrows). These lesions were not visualized with CT but
confirmed during laparotomy. T, primary tumour; M, myocardium
Figure 5 FDG-PET whole-body image of the thorax of a 43-year-old female
patient (patient 9) with a carcinoma of the gastroesophageal junction with
high supraclavicular focal uptake of FDG (arrows). Ultrasound, however,
could not demonstrate the presence of enlarged lymph nodes and the PET
was regarded as false positive. During the follow-up of 1 year no metastases
became manifest. In retrospect, this feature most probably represented
asymmetric uptake in muscles. T, primary tumour; M, myocardium
in three patients (nos 8, 9 and 12). In one patient surgical explo-
ration showed more extensive lymphatic dissemination than
depicted with PET, in the second, suspected distant metastases
were not histologically confirmed and in the third patient the
tumour was resected, but the surgical margins were not free of
tumour. Accuracy of PET was 88% (23/26). CT underestimated
dissemination in seven patients and was inconclusive in two
patients and therefore had an accuracy of65% (17/26). The differ-
ence between CT and PET in estimating resectability was signifi-
cant (P = 0.04; McNemar-test). For CT and PET together accuracy
was 92% (24/26). Laparoscopy incorrectly suggested four out of
seven patients to have a resectable tumour (accuracy 43%).
Resectability based on the EUS result would have been accurate in
four out of seven patients (accuracy 57%).
DISCUSSION
The present study indicates that FDG-PET can be important for
staging patients with oesophageal tumours. The accuracy of PET
for nodal stage was 90% whereas it was 62% with CT. Accuracy of
estimating resectability improved from 65% with CT to 88% with
PET and 92% with both CT and PET.
Preoperative staging is useful ifthe result has an impact on treat-
ment. If surgery is the only therapeutic modality, patients would
benefit from identifying locally advanced tumours (stage IIIB/IV)
when surgery should be avoided. However, increasing use ofmulti-
modality treatment requires more accurate staging to select patients
for stage-dependent treatment concepts (Plukker et al, 1991, 1995;
Bamias et al, 1996; Stahl et al, 1996). Currently, CT, EUS and
laparoscopy are the most frequently used staging methods. In a
retrospective study, Flanagan et al (1991) compared FDG-PET and
CT for staging tumours ofthe oesophagus and found an accuracy of
the detection of nodal involvement of45% for CT, which is some-
what lower than reported in the literature, and 76% for PET, which
is lower than in the current study. The higher spatial resolution of
the PET scanner used in the present study (6 mm vs 10 mm) may
account for this difference (Flanagan, 1997).
Primary tumour stage
The depth of tumour invasion cannot be evaluated accurately by
CT or PET, because both techniques cannot distinguish the indi-
vidual layers of the oesophageal or gastroesophageal junction
wall. The diagnostic accuracy of CT for this purpose is only 50%
(Dittler and Siewert, 1993). With EUS, precise evaluation of
tumour status is possible, although overstaging as a result of
surrounding inflammatory tissue has been reported (Siewert and
Dittler, 1993). In the current study the tumour extension was
underestimated in one patient. This may not be representative,
because the use of EUS in this study was limited. Stenosis does not
hamper EUS much for evaluation of primary tumour status
because it allows the conclusion that the tumour stage is fairly
advanced (Dittler and Siewert, 1993). This conclusion was also
justified in one of our patients.
Nodal stage
EUS is not appropriate for identifying pathological lymph nodes at
the coeliac axis, metastases in the right liver lobe and peritoneal
metastases (Tio et al, 1989; Lightdal, 1992; Dittler and Siewert,
1993). For determining nodal stage, a sensitivity, specificity and
accuracy of 75%, 70% and 73% respectively have been reported
(Lehr et al, 1988). In this study only two out of five patients were
correctly staged with EUS. Therefore, additional imaging tech-
niques remain necessary. CT has an accuracy of56% and 45% for
detecting mediastinal and abdominal lymph node dissemination
respectively (Dittler and Siewert, 1993). We established a sensi-
tivity, specificity and accuracy for correct assessment of nodal
status of 38%, 100% and 62% respectively for CT and 92%, 88%
and 90% respectively for PET. The detection rate of EUS and CT
is directly proportional to the diameter of the lymph nodes.
Secondary EUS signs such as ultrasound pattern and homogeneity
do not improve the results (Grimm et al, 1992). In contrast, PET
does not merely depend on the size of the lesions, but rather on
metabolic activity, and can therefore visualize active lymph nodes
that are not enlarged.
British Journal ofCancer(1998) 78(4), 521-527 . Cancer Research Campaign 1998526 AC Kole et al
Distant metastases
Oesophageal and gastroesophageal junction carcinoma rarely
metastasize early to organs other than lung and liver. CT is there-
fore the best diagnostic means of detecting such metastases. CT
has an accuracy of 80-85% for the detection of liver metastases
(Kemeny et al. 1986: Watt et al, 1989). Six of our 26 patients had
distant metastases. Histological proof was not obtained in three of
these patients because that would not have had any effect on treat-
ment. CT and PET made it very likely that there were in fact
multiple distant metastases. CT missed distant metastases in two
patients in whom PET indicated them clearly. There was one false-
positive result with PET, possibly caused by a concomitant upper
airway infection, and one false-positive result with CT, which
appeared to be a haemangioma of the liver.
Resectability
The ability to achieve complete tumour removal depends on the
TNM stage. The diagnostic accuracy of EUS in determining
resectability is 72-92% (Dittler and Siewert, 1993). For CT we
found 65% and for PET 88%. For CT and PET together this was
92%. In clinical practice, CT of the thorax and the abdomen, EUS
and PET will ideally be performed before proceeding to the more
invasive diagnostic investigations such as laparoscopy and laparo-
tomy. Using this model, CT alone would have prevented 8 of 16
(50%) ill-advised surgical interventions, PET alone 14 (88%) and
CT and PET together 94%. Thus, to save 16 patients surgery, 26
patients would have to undergo CT and PET. Although it is not
possible to determine the exact extension ofthe primary tumour and
therefore it cannot be predicted whether surgical margins will be
free of tumour, these observations suggest that this strategy reduces
morbidity and increases cost-effectiveness. However, there was one
false-positive result. In this case, the PET result was easily checked
with ultrasound of the supraclavicular lymph nodes, and unwanted
consequences were avoided. In theory, chronic pancreatitis and
retroperitoneal fibrosis may cause false-positive results within the
abdominal cavity (Strauss, 1996). PET and CT images from these
diseases tend not to mimic the usual image of pathological lymph
nodes, and will therefore demand further investigation. Similarly,
FDG activity may be seen in the small bowel and more commonly
in the large bowel. This is usually ofrelatively low grade and not of
an intensity that would be mistaken for malignancy (Cook et al,
1996). Inflammatory or reactive lymph nodes can also demonstrate
high metabolic activity and therefore add to the false-positive
results, although we did not meet this problem in the current study.
In the future, multitracer studies with FDG and amino acids may
further reduce the incidence offalse-positive results (Strauss, 1996).
In summary, the preoperative staging results improved with
PET to 90% and 88% for assessing nodal involvement and
resectability respectively. With the combination of CT and PET,
all metastases were detected and a reliable prediction of
resectability was obtained. Such a strategy will reduce the number
of laparotomies performed in vain.
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